[HTML][HTML] COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
I Gilyazova, Y Timasheva, A Karunas… - Non-coding RNA …, 2023 - Elsevier
The novel coronavirus infection (COVID-19) causes a severe acute illness with the
development of respiratory distress syndrome in some cases. COVID-19 is a global problem …
development of respiratory distress syndrome in some cases. COVID-19 is a global problem …
SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad
Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is characterized by important respiratory impairments …
Coronavirus 2 (SARS-CoV-2), is characterized by important respiratory impairments …
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics
K Arman, Z Dalloul, E Bozgeyik - Gene, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection which is
commonly known as COVID-19 (COronaVIrus Disease 2019) has creeped into the human …
commonly known as COVID-19 (COronaVIrus Disease 2019) has creeped into the human …
Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets
X Liu, W Xiong, M Ye, T Lu, K Yuan, S Chang… - … and Targeted Therapy, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …
Noncoding RNAs in the COVID-19 Saga: An Untold Story
In late 2019, the SARS-CoV-2 virus emerged as the cause of COVID-19, triggering a
worldwide pandemic of unprecedented scale. A detailed comprehension is being …
worldwide pandemic of unprecedented scale. A detailed comprehension is being …
microRNAs as the potential regulators of SARS-CoV-2 infection and modifiers of the COVID-19 clinical features
AN Kucher, IA Koroleva, AA Zarubin, MS Nazarenko - Molecular biology, 2022 - Springer
The pandemic of coronavirus disease 2019 (COVID-19) warrants the identification of factors
that may determine both risk and severity of infection. The factors include microRNAs that …
that may determine both risk and severity of infection. The factors include microRNAs that …
Neuropsychiatric and neurodegenerative aspects of acute and long COVID
AF Almulla, HK Al-Hakeim - Frontiers in Molecular Neuroscience, 2023 - frontiersin.org
The escalating prevalence of central nervous system (CNS) symptoms during acute stage
and 3–6 months after coronavirus disease (COVID-19), termed “Long COVID disease,” is a …
and 3–6 months after coronavirus disease (COVID-19), termed “Long COVID disease,” is a …
miRNAs as a potential biomarker in the COVID-19 infection and complications course, severity, and outcome
M Jankovic, D Nikolic, I Novakovic, B Petrovic… - Diagnostics, 2023 - mdpi.com
During the last three years, since the emergence of the COVID-19 pandemic, a significant
number of scientific publications have focused on resolving susceptibility to the infection, as …
number of scientific publications have focused on resolving susceptibility to the infection, as …
Role of microRNAs in cognitive decline related to COVID‑19
A Bougea, VE Georgakopoulou… - Experimental and …, 2024 - spandidos-publications.com
The likelihood and severity of cognitive decline related to coronavirus disease 2019 (COVID‑
19) have been shown to be reflected by the severity of the infection and concomitant …
19) have been shown to be reflected by the severity of the infection and concomitant …
miRNAs in SARS-CoV-2 infection: an update
Coronavirus disease-2019 (COVID-19) is a highly infectious disease caused by newly
discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the …
discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the …